Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey
- PMID: 37479986
- PMCID: PMC10362646
- DOI: 10.1186/s12879-023-08462-y
Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey
Abstract
Background: Between March, 2020 and December, 2021 due to cholera and coronavirus disease 2019 (COVID-19) pandemics, there were 1,534 cholera cases with 14 deaths and 136,065 COVID-19 cases with 3,285 deaths reported respectively in Uganda. This study investigated mass vaccination campaigns for the prevention of the two pandemics namely: oral cholera vaccine (OCV) and COVID-19 vaccine coverage; adverse events following immunization (AEFI); barriers and enablers for the vaccine uptake and assessed water, sanitation and hygiene (WASH) conditions in the six cholera and COVID-19 hotspot districts of Uganda.
Methods: A household survey was conducted between January and February, 2022 in the six cholera hotspot districts of Uganda which had recently conducted OCV mass vaccination campaigns and had ongoing COVID-19 mass vaccination campaigns. The survey randomly enrolled 900 households with 4,315 persons of whom 2,085 were above 18 years. Data were collected using a data entry application designed in KoBoToolbox and analysed using STATA version 14. Frequencies, percentages, odds ratios, means, confidence intervals and maps were generated and interpreted.
Results: The OCV coverage for dose one and two were 85% (95% CI: 84.2-86.4) and 67% (95% CI: 65.6-68.4) respectively. Among the 4,315 OCV recipients, 2% reported mild AEFI, 0.16% reported moderate AEFI and none reported severe AEFI. The COVID-19 vaccination coverage for dose one and two were 69.8% (95% CI: 67.8-71.8) and 18.8% (95% CI: 17.1-20.5) respectively. Approximately, 23% (478/2,085) of COVID-19 vaccine recipient reported AEFI; most 94% were mild, 0.6% were moderate and 2 cases were severe. The commonest reason for missing COVID-19 vaccine was fear of the side effects. For most districts (5/6), sanitation (latrine/toilet) coverage were low at 7.4%-37.4%.
Conclusion: There is high OCV coverage but low COVID-19 vaccine and sanitation coverage with high number of moderate cases of AEFI recorded due to COVID-19 vaccines. The low COVID-19 vaccine coverage could indicate vaccine hesitancy for COVID-19 vaccines. Furthermore, incorporation of WASH conditions assessment in the OCV coverage surveys is recommended for similar settings to generate data for better planning. However, more studies are required on COVID-19 vaccine hesitancy.
Keywords: Adverse event following immunization; Africa; COVID; Cholera; Coronavirus; Pandemic; Sanitation; Uganda; Vaccine coverage; Vaccine hesitancy; WASH; Water coverage.
© 2023. The Author(s).
Conflict of interest statement
All other authors have no competing interests to declare.
Figures






Similar articles
-
The interplay between WASH practices and vaccination with oral cholera vaccines in protecting against cholera in urban Bangladesh: Reanalysis of a cluster-randomized trial.Vaccine. 2023 Mar 31;41(14):2368-2375. doi: 10.1016/j.vaccine.2023.02.054. Epub 2023 Mar 8. Vaccine. 2023. PMID: 36898931 Free PMC article. Clinical Trial.
-
Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.PLoS One. 2018 Oct 3;13(10):e0198592. doi: 10.1371/journal.pone.0198592. eCollection 2018. PLoS One. 2018. PMID: 30281604 Free PMC article.
-
Oral cholera vaccination coverage in an acute emergency setting in Somalia, 2017.Vaccine. 2020 Feb 29;38 Suppl 1:A141-A147. doi: 10.1016/j.vaccine.2020.01.015. Epub 2020 Jan 21. Vaccine. 2020. PMID: 31980193 Review.
-
The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey.BMJ Glob Health. 2020 Jun;5(6):e002431. doi: 10.1136/bmjgh-2020-002431. BMJ Glob Health. 2020. PMID: 32601092 Free PMC article.
-
Global oral cholera vaccine use, 2013-2018.Vaccine. 2020 Feb 29;38 Suppl 1(Suppl 1):A132-A140. doi: 10.1016/j.vaccine.2019.08.086. Epub 2019 Sep 10. Vaccine. 2020. PMID: 31519444 Free PMC article. Review.
Cited by
-
Challenges with achieving and maintaining oral cholera vaccine coverage: insights from serial cross-sectional representative surveys in a cholera-endemic community in the Democratic Republic of the Congo.BMJ Public Health. 2025 Jan 19;3(1):e001035. doi: 10.1136/bmjph-2024-001035. eCollection 2025. BMJ Public Health. 2025. PMID: 40017972 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical